CHI3L1 and myeloid sarcoma: Similarly, CHI3L1 has been associated with neuroinflammation and glial activation in diseases such as Alzheimer’s disease, Parkinson’s disease, traumatic brain injury, and HIV-associated neurocognitive disorders, highlighting its role in chronic inflammatory and neurodegenerative processes beyond MS.